Expect to See More Quadruple Therapy for H. pylori

You'll see changes in preferred drug regimens for H. pylori.

Triple therapy with a PPI and two antibiotics (Prevpac, etc) will fall out of favor. It's not as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.

Expect to see more use of QUADRUPLE therapy and regimens for 14 days instead of 7 to 10 days.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals